Trastuzumab T9912
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
CAS nr:
180288-69-1
Purity:
98%
Molecular Weight:
146000
SMILES:
Formula:
Pathway:
JAK/STAT signaling,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
EGFR,EGFR,EGFR
